Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
24,841,806
-
Share change
-
-395,266
-
Total reported value
-
$2,857,462,500
-
Put/Call ratio
-
64%
-
Price per share
-
$115.03
-
Number of holders
-
307
-
Value change
-
-$68,289,382
-
Number of buys
-
149
-
Number of sells
-
128
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q3 2019
As of 30 Sep 2019,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
307 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,841,806 shares.
The largest 10 holders included
Capital Research Global Investors, FRANKLIN RESOURCES INC, CANADA PENSION PLAN INVESTMENT BOARD, CITADEL ADVISORS LLC, VICTORY CAPITAL MANAGEMENT INC, Capital World Investors, Point72 Asset Management, L.P., PRUDENTIAL PLC, MILLENNIUM MANAGEMENT LLC, and MORGAN STANLEY.
This page lists
307
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.